Quanterix is now "shifting from an R&D phase to a commercial phase" as it prepares to launch its Simoa platform next year.

Julien Bradley, senior director of product management and product marketing at the privately held, Lexington, Mass.-based firm, told BioArray News this week that the company's recent hire of former EMD Millipore executive Paul Chapman as president and CEO is part of that transformation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.